Companies: 10,795·Total market cap: $144.5T
Galecto, Inc.

Galecto, Inc.

GLTONASDAQHealthcare
$21.58
$-0.75(-3.36%)
Market Cap$34470166
P/E Ratio
52W High$38.325
52W Low$2.01
Overview

Galecto, Inc. (GLTO) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · GLTO · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

6

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Galecto, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

GLTO insider buying and selling by quarter

GLTO insider selling · GLTO insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
796K398K0
2025 Q2
2025 Q3
2025 Q4
2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · GLTO ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

GLTO executive sell shares · GLTO board member insider trading · GLTO insider trading SEC filing

Showing 43 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Bruno Julianne

Director

Option

Date

Feb 9

Shares

129,000

Price

Value

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Option

Date

Feb 9

Shares

5,809,000

Price

Value

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Option

Date

Feb 9

Shares

2,904,000

Price

Value

View Form 4 on SEC.gov

Sattarzadeh Sherwin

COO

Award

Date

Jan 5

Shares

190,376

Price

Value

View Form 4 on SEC.gov

Hewes L. Becker

Chief Medical Officer

Award

Date

Jan 5

Shares

264,629

Price

Value

View Form 4 on SEC.gov

Schambye Hans T.

CEO · Director

Option

Date

Jan 2

Shares

1,360

Price

Value

View Form 4 on SEC.gov

Schambye Hans T.

CEO · Director

Sale

Date

Jan 2

Shares

700

Price

$21.38

Value

$15K

View Form 4 on SEC.gov

Winslow Garrett

General Counsel

Option

Date

Jan 2

Shares

680

Price

Value

View Form 4 on SEC.gov

Winslow Garrett

General Counsel

Sale

Date

Jan 2

Shares

255

Price

$21.38

Value

$5K

View Form 4 on SEC.gov

Firmani Lori

CFO

Option

Date

Jan 2

Shares

374

Price

Value

View Form 4 on SEC.gov

Firmani Lori

CFO

Sale

Date

Jan 2

Shares

135

Price

$21.41

Value

$3K

View Form 4 on SEC.gov

Schambye Hans T.

CEO · Director

Option

Date

Jul 3

Shares

1,360

Price

Value

View Form 4 on SEC.gov

Schambye Hans T.

CEO · Director

Sale

Date

Jul 3

Shares

735

Price

$3.38

Value

$2K

View Form 4 on SEC.gov

Winslow Garrett

General Counsel

Option

Date

Jul 3

Shares

680

Price

Value

View Form 4 on SEC.gov

Winslow Garrett

General Counsel

Sale

Date

Jul 3

Shares

260

Price

$3.39

Value

$881

View Form 4 on SEC.gov

Firmani Lori

Interim CFO

Option

Date

Jul 3

Shares

374

Price

Value

View Form 4 on SEC.gov

Firmani Lori

Interim CFO

Sale

Date

Jul 3

Shares

147

Price

$3.39

Value

$498

View Form 4 on SEC.gov

Winslow Garrett

General Counsel

Option

Date

Jan 3

Shares

1,320

Price

Value

View Form 4 on SEC.gov

Winslow Garrett

General Counsel

Sale

Date

Jan 3

Shares

471

Price

$5.60

Value

$3K

View Form 4 on SEC.gov

Firmani Lori

Interim CFO

Option

Date

Jan 3

Shares

726

Price

Value

View Form 4 on SEC.gov

Firmani Lori

Interim CFO

Sale

Date

Jan 3

Shares

261

Price

$5.63

Value

$1K

View Form 4 on SEC.gov

Schambye Hans T.

CEO · Director

Option

Date

Jan 3

Shares

2,640

Price

Value

View Form 4 on SEC.gov

Schambye Hans T.

CEO · Director

Sale

Date

Jan 3

Shares

1,341

Price

$5.60

Value

$8K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

Date

Aug 15

Shares

535,534

Price

$0.75

Value

$402K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

Date

Aug 15

Shares

248,819

Price

$0.75

Value

$187K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About GLTO insider trading

GLTO insider trades

Galecto, Inc. (GLTO) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Schambye Hans T. (CEO · Director), Winslow Garrett (General Counsel), Firmani Lori (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. GLTO insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Galecto, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

GLTO insider trading · 5 questions

The insiders of Galecto, Inc. (GLTO) include executives and directors such as Schambye Hans T. (CEO · Director), Winslow Garrett (General Counsel), Firmani Lori (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

GLTO board member insider tradingwho are GLTO insidersGLTO insider rosterGalecto, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026